Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,000.10 -133.07 -0.88%
S&P 500 1,677.96 -15.91 -0.94%
Nasdaq 3,781.29 -33.73 -0.88%
Ticker Volume Price Price Delta
STOXX 50 2,906.64 -11.67 -0.40%
FTSE 100 6,449.86 +12.36 0.19%
DAX 8,609.41 -20.01 -0.23%
Ticker Volume Price Price Delta
Nikkei 14,157.20 -13.24 -0.09%
Hang Seng 23,214.40 +229.92 1.00%
S&P/ASX 200 5,234.89 +19.33 0.37%
  • Exchange: Xetra
  • Sector: Health Care
  • Industry: Health Care Facilities/Srvcs
  • Sub-Industry: Health Care Facilities

Fresenius SE & Co KGaA

+ Add to Watchlist

FRE:GR

91.920 EUR 0.350 0.38%

As of 11:18:53 ET on 10/03/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Fresenius SE & Co KGaA (FRE)

Open: 91.960 Day's Range: 91.260 - 92.060 Volume: 160,640
Previous Close: 91.570 52wk Range: 81.779 - 100.100 1-Yr Rtn: +0.51%

Stock Chart for FRE

No chart data available.
  • FRE:GR 91.960
  • 1D
  • 1M
  • 1Y
91.570
Interactive FRE Chart

Previous Close

Key Statistics for FRE

Current P/E Ratio (ttm) 17.0951
Estimated P/E(12/2013) 15.6259
Relative P/E vs. DAX 1.1623
Earnings Per Share (EUR) (ttm) 5.3600
Est. EPS (EUR) (12/2013) 5.8640
Est. PEG Ratio 1.2377
Market Cap (M EUR) 16,334.98
Shares Outstanding (M) 178.27
30 Day Average Volume 442,913
Price/Book (mrq) 2.1012
Price/Sale (ttm) 0.8100
Dividend Indicated Gross Yield 1.20%
Cash Dividend (EUR) 1.1000
Dividend Ex-Date 05/20/2013
5 Year Dividend Growth 10.76%
Next Earnings Announcement 11/05/2013
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FRE

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for FRE

Fresenius SE & Co KGaA i s a global health care group with products and services for dialysis, the hospital and the medical care of patients at home. The Company sells dialysis, infusion, transfusion, and diagnostics equipment and systems, blood separators and plasma and hemofilters, nutritional liquids, and solid and liquid pharmaceuticals.

Benjamin J Lipps "Ben"Hon Chairman:Supervisory BoardUlf Mark SchneiderChairman-Mgmt Board
Stephan SturmCFO/Member-Mgmt BoardJuergen GoetzChief Legal & Compliance Ofcr
More Company Profile & Key Executives for FRE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil